123 related articles for article (PubMed ID: 38804222)
1. Predictive Value of Midregional Pro-Atrial Natriuretic Peptide for Cardioembolic Stroke in Hyperacute Ischemic Stroke.
Ikenouchi H; Saito S; Ishiyama H; Kitamura A; Tanaka T; Inoue M; Takahashi Y; Koyama T; Kuriyama N; Koga M; Toyoda K; Urushitani M; Ihara M
J Am Heart Assoc; 2024 Jun; 13(11):e033134. PubMed ID: 38804222
[No Abstract] [Full Text] [Related]
2. Left atrial cross-sectional area is a novel measure of atrial shape associated with cardioembolic strokes.
Tan TC; Nunes MCP; Handschumacher M; Pontes-Neto O; Park YH; O'Brien C; Piro V; Kim GM; Helenius J; Zeng X; Padilha da Silva JL; Furie K; Ay H; Hung J
Heart; 2020 Aug; 106(15):1176-1182. PubMed ID: 31980438
[TBL] [Abstract][Full Text] [Related]
3. Measurement of Midregional Pro-Atrial Natriuretic Peptide to Discover Atrial Fibrillation in Patients With Ischemic Stroke.
Schweizer J; Arnold M; König IR; Bicvic A; Westphal LP; Schütz V; Inauen C; Scherrer N; Luft A; Galovic M; Ferreira Atuesta C; Pokorny T; Arnold M; Fischer U; Bonati LH; De Marchis GM; Kahles T; Nedeltchev K; Cereda CW; Kägi G; Bustamante A; Montaner J; Ntaios G; Sagris D; Foerch C; Spanaus K; von Eckardstein A; Katan M
J Am Coll Cardiol; 2022 Apr; 79(14):1369-1381. PubMed ID: 35393018
[TBL] [Abstract][Full Text] [Related]
4. Artificial Inteligence-Based Decision for the Prediction of Cardioembolism in Patients with Chagas Disease and Ischemic Stroke.
Montanaro VVA; Hora TF; Guerra AA; Silva GS; Bezerra RP; Oliveira-Filho J; Santos LSB; de Melo ES; Alves de Andrade LP; Junior WAO; de Meira FCA; Nunes MDCP; Oliveira EMJ; de Freitas GR
J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):106034. PubMed ID: 34399284
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory and stress markers predicting pneumonia, outcome, and etiology in patients with stroke: Biomarkers for predicting pneumonia, functional outcome, and death after stroke.
Hotter B; Hoffmann S; Ulm L; Montaner J; Bustamante A; Meisel C; Meisel A
Neurol Neuroimmunol Neuroinflamm; 2020 May; 7(3):. PubMed ID: 32098866
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of aged ischemic stroke patients indicative of cardioembolism.
Matsuzono K; Mashiko T; Ozawa T; Miura K; Suzuki M; Furuya K; Ozawa M; Anan Y; Shimazaki H; Koide R; Tanaka R; Kameda T; Fujimoto S
J Thromb Thrombolysis; 2021 Feb; 51(2):522-529. PubMed ID: 32583305
[TBL] [Abstract][Full Text] [Related]
7. Midregional pro-atrial natriuretic peptide and outcome in patients with acute ischemic stroke.
Katan M; Fluri F; Schuetz P; Morgenthaler NG; Zweifel C; Bingisser R; Kappos L; Steck A; Engelter ST; Müller B; Christ-Crain M
J Am Coll Cardiol; 2010 Sep; 56(13):1045-53. PubMed ID: 20846604
[TBL] [Abstract][Full Text] [Related]
8. Automated Electronic Phenotyping of Cardioembolic Stroke.
Guan W; Ko D; Khurshid S; Trisini Lipsanopoulos AT; Ashburner JM; Harrington LX; Rost NS; Atlas SJ; Singer DE; McManus DD; Anderson CD; Lubitz SA
Stroke; 2021 Jan; 52(1):181-189. PubMed ID: 33297865
[TBL] [Abstract][Full Text] [Related]
9. Plasma N-terminal B-Type natriuretic peptide as an indicator of long-term survival after acute myocardial infarction: comparison with plasma midregional pro-atrial natriuretic peptide: the LAMP (Leicester Acute Myocardial Infarction Peptide) study.
Khan SQ; Dhillon O; Kelly D; Squire IB; Struck J; Quinn P; Morgenthaler NG; Bergmann A; Davies JE; Ng LL
J Am Coll Cardiol; 2008 May; 51(19):1857-64. PubMed ID: 18466800
[TBL] [Abstract][Full Text] [Related]
10. BNP combined with echocardiographic parameters to predict the risk of cardioembolic stroke.
Zhang M; Wang Y; Wei J; Peng Q; Pan X; Ma A
J Clin Neurosci; 2021 Jun; 88():213-218. PubMed ID: 33992186
[TBL] [Abstract][Full Text] [Related]
11. Independent Prognostic Value of MRproANP (Midregional Proatrial Natriuretic Peptide) Levels in Patients With Stroke Is Unaltered Over Time.
Arnold M; Nakas C; Luft A; Christ-Crain M; Leichtle A; Katan M
Stroke; 2020 Jun; 51(6):1873-1875. PubMed ID: 32216532
[TBL] [Abstract][Full Text] [Related]
12. Brain natriuretic peptide as a surrogate marker for cardioembolic stroke with paroxysmal atrial fibrillation.
Naya T; Yukiiri K; Hosomi N; Takahashi T; Ohkita H; Mukai M; Koziol JA; Kohno M
Cerebrovasc Dis; 2008; 26(4):434-40. PubMed ID: 18799875
[TBL] [Abstract][Full Text] [Related]
13. Plasma brain natriuretic peptide as a surrogate marker for cardioembolic stroke.
Yukiiri K; Hosomi N; Naya T; Takahashi T; Ohkita H; Mukai M; Masugata H; Murao K; Ueno M; Nakamura T; Dobashi H; Miki T; Kuroda Y; Kohno M
BMC Neurol; 2008 Dec; 8():45. PubMed ID: 19077217
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic ASCOD characterisations of ischaemic stroke in the young at an urban tertiary care centre.
Liu A; Pirastehfar M; Yu D; Linares G
Stroke Vasc Neurol; 2018 Dec; 3(4):209-214. PubMed ID: 30637126
[TBL] [Abstract][Full Text] [Related]
15. Midregional proatrial natriuretic peptide improves risk stratification after ischemic stroke.
De Marchis GM; Schneider J; Weck A; Fluri F; Fladt J; Foerch C; Mueller B; Luft A; Christ-Crain M; Arnold M; Katan M
Neurology; 2018 Feb; 90(6):e455-e465. PubMed ID: 29321236
[TBL] [Abstract][Full Text] [Related]
16. Role of Serum Homocysteine, C-Reactive Protein (CRP), Uric Acid & Pro-Brain Natriuretic Peptide (Pro-BNP) in Predicting the Functional Outcome in Patients with Ischemic Stroke- A Prospective Observational Study from North India.
Chauhan H; Atam V; Sawlani KK; Reddy DH
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443424
[TBL] [Abstract][Full Text] [Related]
17. Inconsistent centralised versus non-centralised ischaemic stroke aetiology.
Suo Y; Jing J; Meng X; Li Z; Pan Y; Jiang Y; Yang X; Liu H; Yan H; Liu L; Zhao X; Wang Y; Li H; Wang Y
Stroke Vasc Neurol; 2020 Dec; 5(4):337-347. PubMed ID: 33154178
[TBL] [Abstract][Full Text] [Related]
18. Atrial Cardiopathy Biomarkers and MRI-Based Infarct Patterns in Patients with Embolic Strokes of Undetermined Source.
Lee YK; Gwak BC; Yoon BA; Kim DH; Cha JK
J Stroke Cerebrovasc Dis; 2021 Aug; 30(8):105933. PubMed ID: 34157668
[TBL] [Abstract][Full Text] [Related]
19. Midregional pro-atrial natriuretic peptide: a novel marker of myocardial fibrosis in patients with hypertrophic cardiomyopathy.
Elmas E; Doesch C; Fluechter S; Freundt M; Weiss C; Lang S; Kälsch T; Haghi D; Papassotiriou J; Kunde J; Schoenberg SO; Borggrefe M; Papavassiliu T
Int J Cardiovasc Imaging; 2011 Apr; 27(4):547-56. PubMed ID: 20872251
[TBL] [Abstract][Full Text] [Related]
20. Impact of Atrial Natriuretic Peptide Value for Predicting Paroxysmal Atrial Fibrillation in Ischemic Stroke Patients.
Shiroto H; Tomita H; Hagii J; Metoki N; Fujita A; Kamada T; Takahashi K; Saito S; Sasaki S; Hitomi H; Seino S; Baba Y; Uchizawa T; Iwata M; Matsumoto S; Yasujima M; Okumura K
J Stroke Cerebrovasc Dis; 2017 Apr; 26(4):772-778. PubMed ID: 27876310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
